Every open market buy and sale of Corbus Pharmaceuticals Holdings, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $126K bought and $2.7M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when CRBP insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an CRBP officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every CRBP insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Cormorant Asset Management, LPFormer 10% Owner | Sale | 425,000 | $4.10 | $1.7M | 1,919,971 | Nov 2Form 4 |
| Sep 14, 2026 | Yong BenDirector | Sale plan | 2,000 | $7.84 | $16K | 9,383 | Sep 15Form 4 |
| Aug 11, 2026 | Nishant C SaxenaChief Business Officer | Buy | 2,600 | $9.63 | $25K | 77,900 | Aug 12Form 4 |
| Aug 7, 2026 | Sean F. MoranCFO | Sale plan | 12,000 | $10.08 | $121K | 84,694 | Aug 10Form 4 |
| Aug 7, 2026 | Yuval CohenCEO | Sale plan | 17,000 | $10.08 | $171K | 157,316 | Aug 10Form 4 |
| Jun 10, 2026 | Anne AltmeyerDirector | Sale plan | 2,412 | $7.91 | $19K | 7,579 | Jun 11Form 4 |
| Jun 10, 2026 | John Kenneth JenkinsDirector | Sale plan | 4,800 | $7.91 | $38K | 3,833 | Jun 11Form 4 |
| Jun 10, 2026 | Winston KungDirector | Sale plan | 2,026 | $7.91 | $16K | 12,140 | Jun 11Form 4 |
| Jun 3, 2026 | Nishant C SaxenaChief Business Officer | Buy | 13,500 | $7.50 | $101K | 75,300 | Jun 3Form 4 |
| Mar 2, 2026 | Dominic SmethurstChief Medical Officer | Sale | 6,097 | $8.30 | $51K | 89,790 | Mar 4Form 4 |
| Feb 17, 2026 | Ian HodgsonCOO | Sale | 847 | $7.38 | $6K | 51,080 | Feb 18Form 4 |
| Feb 13, 2026 | Yuval CohenCEO | Sale plan | 13,871 | $7.78 | $108K | 174,316 | Feb 18Form 4 |
| Feb 13, 2026 | Sean F. MoranCFO | Sale plan | 4,701 | $7.78 | $37K | 96,694 | Feb 18Form 4 |
| Feb 3, 2026 | Ian HodgsonCOO | Sale | 2,415 | $8.09 | $20K | 51,927 | Feb 4Form 4 |
| Feb 3, 2026 | Dominic SmethurstChief Medical Officer | Sale | 3,285 | $8.09 | $27K | 95,887 | Feb 4Form 4 |
CRBP insider trading FAQ
Are CRBP insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $126K of CRBP on the open market in 2 trades, and 10 sold $2.7M in 14 trades, 19% of that under pre-arranged trading plans.
When did an CRBP insider last buy shares?
Nishant C Saxena (Chief Business Officer) bought 2,600 shares for $25K on Aug 11, 2026, reported on Aug 12, 2026.
When did an CRBP insider last sell shares?
Cormorant Asset Management, LP (Former 10% Owner) sold 425,000 shares for $1.7M on Oct 29, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
